Greek startup Intelligencia has received €10.2 million ($12M) of Series A funding in a round led by European health tech investor MTIP. Previous seed-round investors, the Greek Big Pi Ventures and Synetro Group, also participated by global professional services firm ZS.
Intelligencia will use the funds for product development and the expansion of its customer-facing teams. The startup is also to develop new partnerships with clients and partners to incorporate more data in its algorithms.
Company: Intelligencia, Inc.
Round: Series A
Funding Month: August 2021
Leading Investors: MTIP
Additional Investors: Greek Big Pi Ventures, Synetro Group, and ZS
Company Website: http://www.intelligencia.ai/
Software Category: Machine Learning> AI
About the Company: Intelligencia’s mission is to bring innovative therapies to patients faster and with reduced risk by offering drug development, companies machine learning predictions about the trials they conduct and aid their critical decision-making process. The platform’s proprietary algorithms assess more than 1.5B data points across clinical trial design, clinical outcomes, drug biology, funding, regulatory pathways, patients, and medical publications to offer accurate predictions and analysis.